{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/7951"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/7951","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Role of RNA and Protein Synthesis in Rabbit Ovarian Follicular Testosterone Production","abstract":"<p>The role of RNA and protein synthesis in follicular testeterone production has been investigated in the rabbit ovarian follicle in vitro.</p> <p>lsolated follicles were incubated (usually 2 hours) with labeled amino acids or uridine plus LH, cyclic AMP or cyclic GMP alone, or together with various metabolic inhibitors.</p> <p>In dose response studies, testosterone production was stimulated at all concentrations of LH (0.1 to 10 μg/ml) tested (p < .05), with optimal stimulation occurring at 5 μg LH/ml (p < .01). However, a significant uptake of ³H-leucine into follicular protein occurred only at > 2.5 μg LH/ml (p < .01), with optimal stimulation occurring at 5 and 10 μg LH/ml. Cyclic AMP (5 and 10 mM) enhanced both testosterone production and the uptake of ³H-leucine into follicular protein (p < .01). Lower cyclic AMP concentrations were ineffective. Neither LH nor cyclic AMP had any effect on the incorporation of labeled uridine into follicular RNA.</p> <p>In time course studies, testosterone was stimulated within 15 minutes (p < .01), in the presence of LH (5 μg/ml) or cyclic AMP (5 mM). The incorporation of ³H-leucine also increased with time in both LH and cyclic AMP treated follicles, compared to controls, but a significant difference was observed only after 90 and 60 minutes, respectively (p < .01). However, electrophoretic fractionation and radio autographic examination of total follicular proteins after exposure, of LH and ³⁵S-methionine for 15, 60 and 120 minutes showed no apparent difference in the distribution of protein bands when compared to controls.</p> <p>Actinomycin D (20, 80 and 160 μg/ml) together with LH (5 μg/ml) inhibited the incorporation of ³H-uridine into follicular RNA by 79, 85 and 86%, respectively (p < .01). At these concentrations, no inhibitory effect on LH-induced testosterone production was observed. Paradoxically, Actinomycin D (1 μg/ml) enhanced LH-induced testosterone production above that elicited by LH alone.</p> <p>Cycloheximide (20 and 10 μg/ml) inhibited LH-induced testosterone production by 64 and 57% (p < .01), as well as the uptake of ³H-leucine into follicular protein by 94 and 93%, respectively. However, cycloheximide (1 μg/ml) did rot inhibit LH-induced testosterone production, yet inhibited ³H-leucine incorporation by 81.7%. Similarly, puromycin (40 μg/ml) inhibited LH-induced testosterone production by 66%, and the uptake of ³H-leucine into protein by 74% (p < .01). However, puromycin (10, 1 or 0.1 μg/ml) did not inhibit LH-induced testosterone production, yet ³H-leucine incorporation was inhibited by 58, 37 and 31%, respectively (p < .01).</p> <p>The methylxanthines, theophylline (25, 10 and 1 mM) and MIX (5 and 0.5 mM) had no synergistic effects with cyclic AMP on follicular testosterone production. However, these methylxanthines inhibited the incorporation of ³H-uridine (35 to 68%) and ³H-amino acids (45 to 69%) into follicular RNA and protein.</p> <p>Cyclic GMP (25, 10 and 1 mM) had no stimulatory effect on follicular testosterone production or the uptake of protein. However, cyclic GMP (25 and 10 mM) significantly enhanced the uptake of ³H-uridine into follicular RNA (p < .01).</p> <p>These data collectively suggest that de novo RNA and protein synthesis are not required for acute LH-induced testosterone production in the rabbit follicle.</p>","abstract_html":"&lt;p&gt;The role of RNA and protein synthesis in follicular testeterone production has been investigated in the rabbit ovarian follicle in vitro.&lt;/p&gt; &lt;p&gt;lsolated follicles were incubated (usually 2 hours) with labeled amino acids or uridine plus LH, cyclic AMP or cyclic GMP alone, or together with various metabolic inhibitors.&lt;/p&gt; &lt;p&gt;In dose response studies, testosterone production was stimulated at all concentrations of LH (0.1 to 10 μg/ml) tested (p &lt; .05), with optimal stimulation occurring at 5 μg LH/ml (p &lt; .01). However, a significant uptake of ³H-leucine into follicular protein occurred only at &gt; 2.5 μg LH/ml (p &lt; .01), with optimal stimulation occurring at 5 and 10 μg LH/ml. Cyclic AMP (5 and 10 mM) enhanced both testosterone production and the uptake of ³H-leucine into follicular protein (p &lt; .01). Lower cyclic AMP concentrations were ineffective. Neither LH nor cyclic AMP had any effect on the incorporation of labeled uridine into follicular RNA.&lt;/p&gt; &lt;p&gt;In time course studies, testosterone was stimulated within 15 minutes (p &lt; .01), in the presence of LH (5 μg/ml) or cyclic AMP (5 mM). The incorporation of ³H-leucine also increased with time in both LH and cyclic AMP treated follicles, compared to controls, but a significant difference was observed only after 90 and 60 minutes, respectively (p &lt; .01). However, electrophoretic fractionation and radio autographic examination of total follicular proteins after exposure, of LH and ³⁵S-methionine for 15, 60 and 120 minutes showed no apparent difference in the distribution of protein bands when compared to controls.&lt;/p&gt; &lt;p&gt;Actinomycin D (20, 80 and 160 μg/ml) together with LH (5 μg/ml) inhibited the incorporation of ³H-uridine into follicular RNA by 79, 85 and 86%, respectively (p &lt; .01). At these concentrations, no inhibitory effect on LH-induced testosterone production was observed. Paradoxically, Actinomycin D (1 μg/ml) enhanced LH-induced testosterone production above that elicited by LH alone.&lt;/p&gt; &lt;p&gt;Cycloheximide (20 and 10 μg/ml) inhibited LH-induced testosterone production by 64 and 57% (p &lt; .01), as well as the uptake of ³H-leucine into follicular protein by 94 and 93%, respectively. However, cycloheximide (1 μg/ml) did rot inhibit LH-induced testosterone production, yet inhibited ³H-leucine incorporation by 81.7%. Similarly, puromycin (40 μg/ml) inhibited LH-induced testosterone production by 66%, and the uptake of ³H-leucine into protein by 74% (p &lt; .01). However, puromycin (10, 1 or 0.1 μg/ml) did not inhibit LH-induced testosterone production, yet ³H-leucine incorporation was inhibited by 58, 37 and 31%, respectively (p &lt; .01).&lt;/p&gt; &lt;p&gt;The methylxanthines, theophylline (25, 10 and 1 mM) and MIX (5 and 0.5 mM) had no synergistic effects with cyclic AMP on follicular testosterone production. However, these methylxanthines inhibited the incorporation of ³H-uridine (35 to 68%) and ³H-amino acids (45 to 69%) into follicular RNA and protein.&lt;/p&gt; &lt;p&gt;Cyclic GMP (25, 10 and 1 mM) had no stimulatory effect on follicular testosterone production or the uptake of protein. However, cyclic GMP (25 and 10 mM) significantly enhanced the uptake of ³H-uridine into follicular RNA (p &lt; .01).&lt;/p&gt; &lt;p&gt;These data collectively suggest that de novo RNA and protein synthesis are not required for acute LH-induced testosterone production in the rabbit follicle.&lt;/p&gt;","abstract_has_math":false,"creators":["Losier, Joseph Arthur"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Sciences (Growth and Development)","school":null,"contributors":[],"advisors":["YoungLai, E.V."],"committee_chairs":[],"committee_members":[],"year":1979,"date_issued":"1979-04","date_published":"1979-04","updated_at":"2026-11-18T19:32:28Z","subjects":["Medical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/12070"],"render_values":[{"text":"https://doi.org/10.71548/12070","href":"https://doi.org/10.71548/12070","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3193","4213","1466288"],"render_values":[{"text":"opendissertations/3193","href":null,"code":true},{"text":"4213","href":null,"code":true},{"text":"1466288","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/7951","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/7951","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F7951","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["YoungLai, E.V."]},{"key":"dc:contributor.department","label":"Department","values":["Medical Sciences (Growth and Development)"]},{"key":"dc:creator","label":"Author","values":["Losier, Joseph Arthur"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:41:20Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:41:20Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2010-08-23"]},{"key":"dc:date.issued","label":"Date","values":["1979-04"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3193","4213","1466288"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/7951","https://doi.org/10.71548/12070"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The role of RNA and protein synthesis in follicular testeterone production has been investigated in the rabbit ovarian follicle in vitro.</p> <p>lsolated follicles were incubated (usually 2 hours) with labeled amino acids or uridine plus LH, cyclic AMP or cyclic GMP alone, or together with various metabolic inhibitors.</p> <p>In dose response studies, testosterone production was stimulated at all concentrations of LH (0.1 to 10 μg/ml) tested (p < .05), with optimal stimulation occurring at 5 μg LH/ml (p < .01). However, a significant uptake of ³H-leucine into follicular protein occurred only at > 2.5 μg LH/ml (p < .01), with optimal stimulation occurring at 5 and 10 μg LH/ml. Cyclic AMP (5 and 10 mM) enhanced both testosterone production and the uptake of ³H-leucine into follicular protein (p < .01). Lower cyclic AMP concentrations were ineffective. Neither LH nor cyclic AMP had any effect on the incorporation of labeled uridine into follicular RNA.</p> <p>In time course studies, testosterone was stimulated within 15 minutes (p < .01), in the presence of LH (5 μg/ml) or cyclic AMP (5 mM). The incorporation of ³H-leucine also increased with time in both LH and cyclic AMP treated follicles, compared to controls, but a significant difference was observed only after 90 and 60 minutes, respectively (p < .01). However, electrophoretic fractionation and radio autographic examination of total follicular proteins after exposure, of LH and ³⁵S-methionine for 15, 60 and 120 minutes showed no apparent difference in the distribution of protein bands when compared to controls.</p> <p>Actinomycin D (20, 80 and 160 μg/ml) together with LH (5 μg/ml) inhibited the incorporation of ³H-uridine into follicular RNA by 79, 85 and 86%, respectively (p < .01). At these concentrations, no inhibitory effect on LH-induced testosterone production was observed. Paradoxically, Actinomycin D (1 μg/ml) enhanced LH-induced testosterone production above that elicited by LH alone.</p> <p>Cycloheximide (20 and 10 μg/ml) inhibited LH-induced testosterone production by 64 and 57% (p < .01), as well as the uptake of ³H-leucine into follicular protein by 94 and 93%, respectively. However, cycloheximide (1 μg/ml) did rot inhibit LH-induced testosterone production, yet inhibited ³H-leucine incorporation by 81.7%. Similarly, puromycin (40 μg/ml) inhibited LH-induced testosterone production by 66%, and the uptake of ³H-leucine into protein by 74% (p < .01). However, puromycin (10, 1 or 0.1 μg/ml) did not inhibit LH-induced testosterone production, yet ³H-leucine incorporation was inhibited by 58, 37 and 31%, respectively (p < .01).</p> <p>The methylxanthines, theophylline (25, 10 and 1 mM) and MIX (5 and 0.5 mM) had no synergistic effects with cyclic AMP on follicular testosterone production. However, these methylxanthines inhibited the incorporation of ³H-uridine (35 to 68%) and ³H-amino acids (45 to 69%) into follicular RNA and protein.</p> <p>Cyclic GMP (25, 10 and 1 mM) had no stimulatory effect on follicular testosterone production or the uptake of protein. However, cyclic GMP (25 and 10 mM) significantly enhanced the uptake of ³H-uridine into follicular RNA (p < .01).</p> <p>These data collectively suggest that de novo RNA and protein synthesis are not required for acute LH-induced testosterone production in the rabbit follicle.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["Role of RNA and Protein Synthesis in Rabbit Ovarian Follicular Testosterone Production"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["YoungLai, E.V."],"dc:contributor.department":["Medical Sciences (Growth and Development)"],"dc:creator":["Losier, Joseph Arthur"],"dc:date.accessioned":["2014-06-18T16:41:20Z"],"dc:date.available":["2014-06-18T16:41:20Z"],"dc:date.created":["2010-08-23"],"dc:date.issued":["1979-04"],"dc:description.abstract":["<p>The role of RNA and protein synthesis in follicular testeterone production has been investigated in the rabbit ovarian follicle in vitro.</p> <p>lsolated follicles were incubated (usually 2 hours) with labeled amino acids or uridine plus LH, cyclic AMP or cyclic GMP alone, or together with various metabolic inhibitors.</p> <p>In dose response studies, testosterone production was stimulated at all concentrations of LH (0.1 to 10 μg/ml) tested (p < .05), with optimal stimulation occurring at 5 μg LH/ml (p < .01). However, a significant uptake of ³H-leucine into follicular protein occurred only at > 2.5 μg LH/ml (p < .01), with optimal stimulation occurring at 5 and 10 μg LH/ml. Cyclic AMP (5 and 10 mM) enhanced both testosterone production and the uptake of ³H-leucine into follicular protein (p < .01). Lower cyclic AMP concentrations were ineffective. Neither LH nor cyclic AMP had any effect on the incorporation of labeled uridine into follicular RNA.</p> <p>In time course studies, testosterone was stimulated within 15 minutes (p < .01), in the presence of LH (5 μg/ml) or cyclic AMP (5 mM). The incorporation of ³H-leucine also increased with time in both LH and cyclic AMP treated follicles, compared to controls, but a significant difference was observed only after 90 and 60 minutes, respectively (p < .01). However, electrophoretic fractionation and radio autographic examination of total follicular proteins after exposure, of LH and ³⁵S-methionine for 15, 60 and 120 minutes showed no apparent difference in the distribution of protein bands when compared to controls.</p> <p>Actinomycin D (20, 80 and 160 μg/ml) together with LH (5 μg/ml) inhibited the incorporation of ³H-uridine into follicular RNA by 79, 85 and 86%, respectively (p < .01). At these concentrations, no inhibitory effect on LH-induced testosterone production was observed. Paradoxically, Actinomycin D (1 μg/ml) enhanced LH-induced testosterone production above that elicited by LH alone.</p> <p>Cycloheximide (20 and 10 μg/ml) inhibited LH-induced testosterone production by 64 and 57% (p < .01), as well as the uptake of ³H-leucine into follicular protein by 94 and 93%, respectively. However, cycloheximide (1 μg/ml) did rot inhibit LH-induced testosterone production, yet inhibited ³H-leucine incorporation by 81.7%. Similarly, puromycin (40 μg/ml) inhibited LH-induced testosterone production by 66%, and the uptake of ³H-leucine into protein by 74% (p < .01). However, puromycin (10, 1 or 0.1 μg/ml) did not inhibit LH-induced testosterone production, yet ³H-leucine incorporation was inhibited by 58, 37 and 31%, respectively (p < .01).</p> <p>The methylxanthines, theophylline (25, 10 and 1 mM) and MIX (5 and 0.5 mM) had no synergistic effects with cyclic AMP on follicular testosterone production. However, these methylxanthines inhibited the incorporation of ³H-uridine (35 to 68%) and ³H-amino acids (45 to 69%) into follicular RNA and protein.</p> <p>Cyclic GMP (25, 10 and 1 mM) had no stimulatory effect on follicular testosterone production or the uptake of protein. However, cyclic GMP (25 and 10 mM) significantly enhanced the uptake of ³H-uridine into follicular RNA (p < .01).</p> <p>These data collectively suggest that de novo RNA and protein synthesis are not required for acute LH-induced testosterone production in the rabbit follicle.</p>"],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.other":["opendissertations/3193","4213","1466288"],"dc:identifier.uri":["http://hdl.handle.net/11375/7951","https://doi.org/10.71548/12070"],"dc:subject":["Medical Sciences"],"dc:title":["Role of RNA and Protein Synthesis in Rabbit Ovarian Follicular Testosterone Production"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:32:28Z"}